Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005829 | cytosol | 2 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QDP0
Term | Name | Level | Count |
---|---|---|---|
GO:0002097 | tRNA wobble base modification | 7 | 2 |
GO:0002098 | tRNA wobble uridine modification | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006417 | regulation of translation | 6 | 10 |
GO:0006448 | regulation of translational elongation | 7 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009058 | biosynthetic process | 2 | 10 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009889 | regulation of biosynthetic process | 4 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0010468 | regulation of gene expression | 5 | 10 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 10 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 10 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0017182 | peptidyl-diphthamide metabolic process | 7 | 10 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 4 | 10 |
GO:0018193 | peptidyl-amino acid modification | 5 | 10 |
GO:0018202 | peptidyl-histidine modification | 6 | 10 |
GO:0019222 | regulation of metabolic process | 3 | 10 |
GO:0019538 | protein metabolic process | 3 | 10 |
GO:0031323 | regulation of cellular metabolic process | 4 | 10 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 10 |
GO:0034248 | regulation of amide metabolic process | 5 | 10 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0036211 | protein modification process | 4 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0043412 | macromolecule modification | 4 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0044249 | cellular biosynthetic process | 3 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0050789 | regulation of biological process | 2 | 10 |
GO:0050794 | regulation of cellular process | 3 | 10 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 10 |
GO:0051246 | regulation of protein metabolic process | 5 | 10 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 10 |
GO:0065007 | biological regulation | 1 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0080090 | regulation of primary metabolic process | 4 | 10 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1900247 | regulation of cytoplasmic translational elongation | 8 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 10 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043169 | cation binding | 3 | 11 |
GO:0046872 | metal ion binding | 4 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.306 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.293 |
DOC_PP2B_LxvP_1 | 19 | 22 | PF13499 | 0.276 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.656 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.499 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.395 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.534 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.406 |
LIG_14-3-3_CanoR_1 | 9 | 16 | PF00244 | 0.426 |
LIG_APCC_ABBA_1 | 144 | 149 | PF00400 | 0.506 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.644 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.424 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.556 |
LIG_FHA_2 | 12 | 18 | PF00498 | 0.393 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.280 |
LIG_LIR_Gen_1 | 105 | 115 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 14 | 23 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 69 | 76 | PF02991 | 0.336 |
LIG_LIR_LC3C_4 | 175 | 180 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 11 | 16 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 69 | 73 | PF02991 | 0.327 |
LIG_PDZ_Class_2 | 179 | 184 | PF00595 | 0.461 |
LIG_Pex14_2 | 66 | 70 | PF04695 | 0.340 |
LIG_PTAP_UEV_1 | 22 | 27 | PF05743 | 0.240 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.441 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.563 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.240 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.490 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.318 |
MOD_CK2_1 | 11 | 17 | PF00069 | 0.514 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.418 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.683 |
MOD_GlcNHglycan | 153 | 156 | PF01048 | 0.662 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.416 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.324 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.371 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.361 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.452 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.389 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.406 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.321 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.523 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.642 |
MOD_OFUCOSY | 171 | 176 | PF10250 | 0.440 |
MOD_PIKK_1 | 91 | 97 | PF00454 | 0.475 |
MOD_PKA_1 | 53 | 59 | PF00069 | 0.340 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.340 |
MOD_PKA_2 | 8 | 14 | PF00069 | 0.435 |
MOD_Plk_2-3 | 106 | 112 | PF00069 | 0.475 |
MOD_Plk_4 | 106 | 112 | PF00069 | 0.475 |
MOD_Plk_4 | 174 | 180 | PF00069 | 0.364 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.410 |
TRG_ENDOCYTIC_2 | 108 | 111 | PF00928 | 0.420 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.280 |
TRG_ER_diArg_1 | 115 | 118 | PF00400 | 0.503 |
TRG_ER_diArg_1 | 126 | 129 | PF00400 | 0.515 |
TRG_Pf-PMV_PEXEL_1 | 167 | 172 | PF00026 | 0.423 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKZ1 | Leptomonas seymouri | 55% | 100% |
A0A0S4JNU9 | Bodo saltans | 40% | 100% |
A0A1X0P737 | Trypanosomatidae | 41% | 100% |
A0A3S7WV53 | Leishmania donovani | 92% | 100% |
A0A422NIQ2 | Trypanosoma rangeli | 43% | 100% |
A4H9Q3 | Leishmania braziliensis | 66% | 99% |
A4HY19 | Leishmania infantum | 92% | 100% |
D0A566 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9ART3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q0VBY7 | Bos taurus | 26% | 100% |
Q6P3W2 | Homo sapiens | 27% | 100% |